After Chris and Quiznosana said goodbye to each other on the phone, Marloy Smith also drove his car to the entrance of Classy Mansion.
Along with Overl, the general manager of AB Pharmaceutical, Fabian, came out to greet him.
When he saw Chris, Fabian hurriedly and respectfully came forward and said, "Lord Arthur!"
Chris did not expect Fabian to come so quickly, and could not help but laugh: "How did you get here so quickly?"
Fabian said, "Mr. Smith said you were looking for me for something, so I rushed over."
Chris nodded and smiled: "Looking for you to talk about the new drug, come in let's talk."
Overl hurriedly said, "Lord Arthur, the diamond box is ready, please!"
Chris then said, "Let's all join together."
a couple people came to the diamond box with Chris, and after they were seated, he asked Fabian straight to the point: "How is the recent business situation of the company?"
Fabian could not hide his excitement and said, "Lord Arthur, our AB wopple is selling very well now, and has successfully entered the markets of some developed countries in Europe and the Americas, with global monthly sales of more than 2 billion, and it is rising.
Chris didn't feel much when he heard this data, instead, Marloy Smith was shocked and asked, "The global sales of AB wopple alone exceeded 2 billion in 1 month?"
Fabian laughed: "Mr. Smith, this is only 1/2 of the situation in developed countries in Europe and the U.S."
"You know, AB wopple in overseas, no matter which country's currency, the actual pricing converted into U.S. dollars exchange rate, is about 1 hundred U.S. dollars, equivalent to about 6 hundred."
"This deducts the production costs, tariffs, and corporate income tax, and then deduct the channel costs, publicity The net profit is about 40 to 50 percent."
Marloy Smith could not help but exclaim: "If all the European and American countries are taken, won't it be possible to double?"
"Yes." Fabian explained, "In many countries of Europe and in the U.S for overseas import drug approval is relatively strict, need us to produce relatively complete pharmacological experiments as well as clinical trial data, and even pharmacokinetics."
"These also require us to give detailed data, the most headache is that they need us to have to publish the prescription, this we are still negotiating with the relevant local agencies."
Chris said lightly: "AB Pharmaceutical's prescription, is absolutely impossible to leak out, this they do not even have to think about."
Fabian said with more or less difficulty: "But Lord Arthur…… if the other side insists, if we do not agree, the other side will not approve our drugs to be marketed in their country."
Chris asked rhetorically, "Is there nothing special about this kind of policy?"
"There is……" Fabian explained: "If it is a high mortality rate of major disease-related special drugs, some cases are able to get special approval."
"But that is basically some for cancer, cardiovascular disease Similar to these high mortality rate of serious illnesses, or for diabetes, a chronic disease that requires long-term medication."
"If there are special drugs in these regions, they will generally open an opening to let the drug in 1st."
To be continued...
Share
